{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:29:24Z","timestamp":1768422564108,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Improved treatment of childhood acute lymphoblastic leukemia (ALL) depends on the identification of new molecular markers that can predict treatment response and clinical outcome. Examination of the expression patterns of a set of genes at the RNA level is one of these new modalities. The prognostic significance of caspase-8-associated protein 2 (CASP8AP2), an apoptosis-related gene, in pediatric ALL is controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective study of 70 newly diagnosed ALL patients who were treated in the National Cancer Institute (NCI), Cairo University during the period from 1st of October 2019 till the end of September 2023, to measure the CASP8AP2 expression level in bone marrow samples at the time of diagnosis and at the end of induction therapy using real-time quantitative PCR, and to assess its relation with different prevalent prognostic variables and disease outcome. All cases were followed up till end of December 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher initial CASP8AP2 gene expression was associated with hyperdiploid karyotyping (p\u2009=\u20090.009), molecularly favorable mutations (p\u2009=\u20090.002), early induction response (p\u2009=\u20090.025), and low-risk patients (p\u2009&lt;\u20090.001) and had a significant impact on lowering events in the first 3 years of follow-up (p\u2009=\u20090.001). Meanwhile, examining post-induction gene levels failed to show similar results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher initial CASP8AP2 gene expression was associated with favorable impact on event-free survival in pediatric ALL patients. Post-induction levels did not show similar correlation. Future larger studies are needed to confirm the favorable association and to search for other possibly related prognostic factors to further refine risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-025-04147-x","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:35:15Z","timestamp":1765431315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of caspase 8 associated protein 2 (CASP8AP2) in childhood b cell acute lymphoblastic Leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Omar","family":"Arafah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marihame","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Mustafa","family":"Abd Elsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Elfishawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"1","key":"4147_CR1","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1038\/s41598-020-63528-0","volume":"10","author":"A Kakaje","year":"2020","unstructured":"Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, et al. Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep. 2020;10(1):6756. https:\/\/doi.org\/10.1038\/s41598-020-63528-0.","journal-title":"Sci Rep"},{"key":"4147_CR2","unstructured":"National Cancer Institute: NCCR*Explorer: an interactive website for NCCR cancer statistics. Bethesda, MD: National Cancer Institute.\u00a0Available online. Last accessed February 25, 2025."},{"issue":"27","key":"4147_CR3","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9397","volume":"31","author":"AV Moorman","year":"2013","unstructured":"Moorman AV, Robinson H, Schwab C, Richer H, Hancock J, Mitchell CD, et al. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97 and UKALL2003 trials. J Clin Oncol. 2013;31(27):3389\u201396. https:\/\/doi.org\/10.1200\/JCO.2013.48.9397.","journal-title":"J Clin Oncol"},{"issue":"9","key":"4147_CR4","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.21873\/anticanres.13717","volume":"39","author":"E Demidowicz","year":"2019","unstructured":"Demidowicz E, Pogorzala M, \u0141\u0119cka M, Zo\u0142nowska H, Marja\u0144ska A, Kubicka M, et al. Outcome of pediatric acute lymphoblastic leukemia: sixty years of progress. Anticancer Res. 2019;39(9):5203\u20137. https:\/\/doi.org\/10.21873\/anticanres.13717.","journal-title":"Anticancer Res"},{"issue":"18","key":"4147_CR5","doi-asserted-by":"publisher","first-page":"12475","DOI":"10.1074\/jbc.M50989200","volume":"281","author":"P Jostins","year":"2006","unstructured":"Jostins P, Schaue-Obsthof K, Schwerk C. Loss of caspases inhibits oligonucleosomal DNA fragmentation but not chromatin condensation during apoptosis. J Biol Chem. 2006;281(18):12475\u201384. https:\/\/doi.org\/10.1074\/jbc.M50989200.","journal-title":"J Biol Chem"},{"issue":"2","key":"4147_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1044-579X(02)00132-1","volume":"13","author":"KM Debatin","year":"2003","unstructured":"Debatin KM, Stahnke K, Fulda S. Apoptosis in hematological disorders. Semin Cancer Biol. 2003;13(2):149\u201358. https:\/\/doi.org\/10.1016\/S1044-579X(02)00132-1.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4147_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ydbio.2003.09.030","volume":"265","author":"R Morgan","year":"2004","unstructured":"Morgan R, K\u00e4lli A, Morsi El-Kadi AS. FLASH, a component of the FAS\u2013CAPS8AP8 apoptotic pathway, is directly regulated by hDex1 in the notochord. Dev Biol. 2004;265(1):105\u201312. https:\/\/doi.org\/10.1016\/j.ydbio.2003.09.030.","journal-title":"Dev Biol"},{"issue":"2","key":"4147_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.molcel.2009.08.010","volume":"36","author":"YC Yang","year":"2009","unstructured":"Yang YC, Burch BD, Yan Y, Marzluff WF, Dominski Z. FLASH: a proapoptotic protein involved in activation of caspase-8, is essential for 3\u2032-end processing of histone pre-mRNAs. Mol Cell. 2009;36(2):267\u201378. https:\/\/doi.org\/10.1016\/j.molcel.2009.08.010.","journal-title":"Mol Cell"},{"issue":"23","key":"4147_CR9","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1182\/blood-2010-01-259585","volume":"115","author":"J Gregers","year":"2011","unstructured":"Gregers J, Christensen IJ, Dalhoff K, Lausen B, Schr\u00f8der H, Rosth\u00f8j S, et al. The association of reduced folate carrier 80A: G polymorphism outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number. Blood. 2011;115(23):4671\u20137. https:\/\/doi.org\/10.1182\/blood-2010-01-259585.","journal-title":"Blood"},{"issue":"48","key":"4147_CR10","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1038\/onc.2008.297","volume":"27","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yuan J. Caspases in apoptosis and beyond. Oncogene. 2008;27(48):6194\u2013206. https:\/\/doi.org\/10.1038\/onc.2008.297.","journal-title":"Oncogene"},{"issue":"15","key":"4147_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350(15):1535\u201348. https:\/\/doi.org\/10.1056\/NEJMra023001.","journal-title":"N Engl J Med"},{"key":"4147_CR12","doi-asserted-by":"publisher","unstructured":"Gohar S, Shloom I, Assem M, Attia I, Yassin D, Salem S, et al. Clinical significance of minimal residual disease in peripheral blood on day 8 induction in childhood B-precursor acute lymphoblastic leukemia: report from Children\u2019s Cancer Hospital in Egypt. 2015;33:115. suppl.2:e1008\u2013e21008. https:\/\/doi.org\/10.1200\/jco.2015.33.15_suppl.e21008.","DOI":"10.1200\/jco.2015.33.15_suppl.e21008"},{"key":"4147_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jnci.2013.05.004","volume":"25","author":"M Sarma","year":"2013","unstructured":"Sarma M, Mahmoud H, Abdelhamid T, El-Sharkawy N, ElNahas Y, El Gammal M, et al. The prognostic significance of minimal residual disease in adult Egyptian patients with precursor acute lymphoblastic leukemia. J Egypt Natl Cancer Inst. 2013;25:135\u201342. https:\/\/doi.org\/10.1016\/j.jnci.2013.05.004.","journal-title":"J Egypt Natl Cancer Inst"},{"key":"4147_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clml.2016.02.023","volume":"16","author":"S Adnan Awad","year":"2016","unstructured":"Adnan Awad S, Kamel MM, Ayoub MA, Kamel AM, Elnoshokaty EH, El Hifnawi N. Immunophenotypic characterization of genotype subgroups in Egyptian pediatric patients with B-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2016;16:519\u201324. https:\/\/doi.org\/10.1016\/j.clml.2016.02.023.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"4147_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-020-00065-5","volume":"21","author":"Farweez BAT","year":"2020","unstructured":"Farweez BAT, Kassim NA, Abdelfattah MF, Hassan NM, Hassan DEA, El-Sharkawy M. Clinical impact of early minimal residual disease detection at day 15 in precursor B-childhood acute lymphoblastic leukemia: an Egyptian experience. Egypt J Med Hum Genet. 2020;21(1):28. https:\/\/doi.org\/10.1186\/s43042-020-00065-5.","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"4147_CR16","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.1038\/s41598-019-47020-y","volume":"9","author":"S Basu","year":"2019","unstructured":"Basu S, Pereira AF, Pineiro DH, Wang H, Valencia-Jimenez A, Siegfried BD, et al. Evaluation of reference genes for real-time quantitative PCR analysis in southern corn rootworm, Diabrotica undecimpunctata howardi (Barber). Sci Rep. 2019;9(1):10374. https:\/\/doi.org\/10.1038\/s41598-019-47020-y.","journal-title":"Sci Rep"},{"issue":"3","key":"4147_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, Heyman M, et al. Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia. 2018;32(3):606\u201315. https:\/\/doi.org\/10.1038\/leu.2017.265.","journal-title":"Leukemia"},{"issue":"16","key":"4147_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood.2019010043","volume":"16","author":"SP Hunger","year":"2023","unstructured":"Hunger SP, Raetz EA. How i treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 2023;16(16):1803\u201312. https:\/\/doi.org\/10.1182\/blood.2019010043.","journal-title":"Blood"},{"issue":"3","key":"4147_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.leukres.2007.04.021","volume":"31","author":"D Cathpole","year":"2007","unstructured":"Cathpole D, Lai A, Guo D, Chen QR, Khan J. Gene expression in fresh state segregate patients with childhood acute lymphoblastic leukemia: an independent validation study identifies that endoglin is associated with patient outcome. Leuk Res. 2007;31(3):221\u20137. https:\/\/doi.org\/10.1016\/j.leukres.2007.04.021.","journal-title":"Leuk Res"},{"key":"4147_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2019.00192","volume":"12","author":"H McBride","year":"2019","unstructured":"McBride H, Aouacheria A, Widlak P, Viegas L, Ciech N, Kasner M, et al. The role of inhibition of apoptosis in acute leukemias and myelodysplastic syndrome. Front. 2019;12:192. https:\/\/doi.org\/10.3389\/fonc.2019.00192.","journal-title":"Front"},{"issue":"13","key":"4147_CR21","doi-asserted-by":"publisher","first-page":"007","DOI":"10.1182\/blood-2006-01-0322","volume":"108","author":"C Flohr","year":"2006","unstructured":"Flohr C, Coustan-Smith E, Pei D, Ivamoto S, Song G, Cheng C, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood. 2006;108(13):007\u201315. https:\/\/doi.org\/10.1182\/blood-2006-01-0322.","journal-title":"Blood"},{"issue":"4","key":"4147_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1182\/blood-2007-01-064878","volume":"110","author":"E Coustan-Smith","year":"2007","unstructured":"Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;110(4):1271\u20137. https:\/\/doi.org\/10.1182\/blood-2007-01-064878.","journal-title":"Blood"},{"issue":"3","key":"4147_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.leukres.2011.05.023","volume":"26","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Cui L, Gao C, Li W, Zhao X, Lu S, et al. CASP8AP2 is a promising diagnostic biomarker in pediatric acute lymphoblastic leukemia. Leukemia Res. 2013;26(3):167\u201371. https:\/\/doi.org\/10.1016\/j.leukres.2011.05.023.","journal-title":"Leukemia Res"},{"issue":"3","key":"4147_CR24","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1097\/MPH.0000000000002558","volume":"45","author":"JF Jin","year":"2023","unstructured":"Jin JF, Wang CJ, Cui L, Liu FF, Wang KL, Li WJ, et al. Interaction of E2F3a and CASP8AP2 regulates histone expression and chemosensitivity of leukemic cells. J Pediatr Hematol Oncol. 2023;45(3):e339\u201344. https:\/\/doi.org\/10.1097\/MPH.0000000000002558.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4147_CR25","doi-asserted-by":"crossref","unstructured":"Juarez-Velazquez MR, Salas-Labadia C, Reyes-Leon A, Navarrete-Meneses MP, Fuentes-Panana EM, Perez-Ver P. Genetic markers in the prognosis of childhood acute lymphoblastic leukemia. In: Mejia-Arangure JM, editor. Clinical epidemiology of acute lymphoblastic leukemia\u2014from the molecules to the clinic [Internet]. InTech; 2013 [cited 2022 Feb 5]. Available from: http:\/\/www.intechopen.com\/books\/clinical-epidemiology-of-acute-lymphoblastic-leukemia-from-the-molecules-to-the-clinic\/genetic-markers-in-the-prognosis-of-childhood-acute-lymphoblastic-leukemia","DOI":"10.5772\/54288"},{"issue":"1","key":"4147_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0531-1","volume":"18","author":"FF Liu","year":"2018","unstructured":"Liu FF, Wang KL, Deng LP, Liu X, Wu MY, Wang TY, et al. Transcription factor E2F3a regulates CASP8AP2 transcription and enhances sensitivity to chemotherapeutic drugs in acute lymphoblastic leukemia. Cancer Cell Int. 2018;18(1):1\u20139. https:\/\/doi.org\/10.1186\/s12935-018-0531-1.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"4147_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","volume":"114","author":"M Remke","year":"2009","unstructured":"Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-\u03b2 and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood. 2009;114(5):1053\u201362. https:\/\/doi.org\/10.1182\/blood-2008-10-186536.","journal-title":"Blood"},{"issue":"7","key":"4147_CR28","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","volume":"115","author":"H Kang","year":"2010","unstructured":"Kang H, Chen IM, Wilson CS, Bedrick EJ, Harvey RC, Atlas SR, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010;115(7):1394\u2013405. https:\/\/doi.org\/10.1182\/blood-2009-05-218560.","journal-title":"Blood"},{"issue":"1","key":"4147_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.leukres.2009.07.023","volume":"34","author":"YL Yang","year":"2010","unstructured":"Yang YL, Lin SR, Chen JS, Lin SW, Yu SL, Chen HY, et al. Expression and prognostic significance of the apoptotic genes BCL2L13, livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. Leuk Res. 2010;34(1):18\u201323. https:\/\/doi.org\/10.1016\/j.leukres.2009.07.023.","journal-title":"Leuk Res"},{"issue":"24","key":"4147_CR30","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1158\/1078-0432.CCR-11-0513","volume":"17","author":"H Ehrhardt","year":"2011","unstructured":"Ehrhardt H, Wachter F, Maurer M, Stahnke K, Jeremias I. Important role of caspase-8 for chemosensitivity of ALL cells. Clin Cancer Res. 2011;17(24):7605\u201313. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0513.","journal-title":"Clin Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04147-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04147-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:22:09Z","timestamp":1768389729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04147-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04147-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of National Cancer Institute, Cairo University\u2013Egypt (NCI) IRB approval number (2110-407-018) in October 2022. Informed consent was obtained from all subjects involved in the study. Informed consent was obtained from patients\u2019 parents or legal guardians involved in the study. They had read and understood all the necessary information regarding the study (Study aim, methods, benefits and possible risk if any, and expected results). They agreed to use and protect their data and gave their consent to participate completely voluntarily. They were informed that they can freely withdraw from the study at any time without reasoning and without affecting their future care. The study used archived data and did not affect patient well-being in any way. Patients\u2019 confidentiality was always maintained in accordance with National Cancer Institute, Cairo University policies. Data collection and presentation were anonymous and both privacy and confidentiality were protected to the maximal possible standard.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors confirm that study participants provided informed consent for publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from patients\u2019 parents or legal guardian in the case of children under 18 years of age was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}